Proteome Sciences PLC PMSNF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.08
- Day Range
- $0.05–0.05
- 52-Week Range
- $0.03–0.09
- Bid/Ask
- $0.02 / $0.13
- Market Cap
- $16.12 Mil
- Volume/Avg
- 1,000 / 2,000
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.72
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Proteome Sciences PLC is protein biomarker research and development. provider of contract research services for the identification, validation and application of protein biomarkers. Its only reportable segment is the sale of goods and biomarker services. It generates maximum revenue from the TMT product and end customer sales-based royalties. Geographically, it has a presence in the United States, the United Kingdom, the European Union, and Other.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Growth
- Total Number of Employees
- 31
- Website
- https://www.proteomics.com
Valuation
|
Metric
|
PMSNF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 2.72 |
Price/Cash Flow | — |
Price/Earnings
PMSNF
Financial Strength
|
Metric
|
PMSNF
|
|---|---|
Quick Ratio | 0.25 |
Current Ratio | 0.33 |
Interest Coverage | −2.03 |
Quick Ratio
PMSNF
Profitability
|
Metric
|
PMSNF
|
|---|---|
Return on Assets (Normalized) | −19.37% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −15.42% |
Return on Assets
PMSNF
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Qrlscyhss | Ppzp | $231.8 Bil | |||
| Danaher Corp
DHR
| Fmvhyjkxnx | Zydlpn | $197.8 Bil | |||
| IQVIA Holdings Inc
IQV
| Kknrthg | Zmnny | $43.7 Bil | |||
| Agilent Technologies Inc
A
| Cyrpvrlmv | Hbmd | $40.1 Bil | |||
| IDEXX Laboratories Inc
IDXX
| Zsgyqmss | Jzjdn | $38.8 Bil | |||
| Mettler-Toledo International Inc
MTD
| Vrsspcql | Qczjn | $31.0 Bil | |||
| Icon PLC
ICLR
| Bbxmwrhj | Dncfn | $26.8 Bil | |||
| Illumina Inc
ILMN
| Rntmvqqyv | Yqxmcl | $19.2 Bil | |||
| Waters Corp
WAT
| Wfdpxmgn | Pgxv | $18.9 Bil | |||
| Labcorp Holdings Inc
LH
| Wbynffhbr | Vygzmx | $17.8 Bil |